Home › Funds › MAVERICK CAPITAL LTD › RGEN

MAVERICK CAPITAL LTD position in RGEN

REPLIGEN CORP · Health Care

MAVERICK CAPITAL LTD reported holding 1,984,554 shares of RGEN (REPLIGEN CORP) in its Q2 2026 13F filing — a position valued at US$270.8M, representing 2.52% of its reported portfolio and ranking #15 among its reported holdings. MAVERICK CAPITAL LTD has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.98M sh
Reported value held$270.77M
Portfolio Weight2.52%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MAVERICK CAPITAL LTD's RGEN position evolved

MAVERICK CAPITAL LTD first disclosed a stake in RGEN in Q1 2026 at 1,518,805 shares (US$178.9M). The position peaked in Q2 2026 at 1,984,554 shares, worth US$270.8M. Across 2 filings, MAVERICK CAPITAL LTD increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,984,554 shares valued at US$270.8M — an increase of 465,749 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.52M $178.95M New
Q2 2026 1.98M $270.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 32 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), CONGRESS ASSET MANAGEMENT CO (US$196.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has MAVERICK CAPITAL LTD held RGEN?

MAVERICK CAPITAL LTD has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is MAVERICK CAPITAL LTD's current position in RGEN?

As of Q2 2026, MAVERICK CAPITAL LTD holds 1.98M shares of RGEN (REPLIGEN CORP), valued at $270.77M, representing 2.52% of its reported portfolio and ranking #15.

Has MAVERICK CAPITAL LTD been buying or selling RGEN?

In the latest 13F filing (Q2 2026), MAVERICK CAPITAL LTD increased its position in RGEN. The position peaked in Q2 2026 at 1.98M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, CONGRESS ASSET MANAGEMENT CO, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.